Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Receivables - Net: 2023-2024

Historic Receivables - Net for BioLineRx (BLRX) over the last 2 years, with Dec 2024 value amounting to $2.5 million.

  • BioLineRx's Receivables - Net fell 97.55% to $78,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $78,000, marking a year-over-year decrease of 97.55%. This contributed to the annual value of $2.5 million for FY2024, which is 591.62% up from last year.
  • BioLineRx's Receivables - Net amounted to $2.5 million in FY2024, which was up 591.62% from $358,000 recorded in FY2023.
  • Over the past 5 years, BioLineRx's Receivables - Net peaked at $2.5 million during FY2024, and registered a low of $358,000 during FY2023.
  • Moreover, its 2-year median value for Receivables - Net was $1.4 million (2023), whereas its average is $1.4 million.
  • Data for BioLineRx's Receivables - Net shows a peak YoY skyrocketed of 591.62% (in 2024) over the last 5 years.
  • Over the past 2 years, BioLineRx's Receivables - Net (Yearly) stood at $358,000 in 2023, then soared by 591.62% to $2.5 million in 2024.